Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injectables and syrups. The company also operates as a contract development and manufacturing organization (CDMO) for various leading pharmaceutical companies.
Financial Results:
Sakar Healthcare Ltd reported Revenues for Q1FY24 of ₹38.99 Crores up from ₹28.53 Crore year on year, a rise of 36.66%.
Total Expenses for Q1FY24 of ₹36.56 Crores up from ₹25.00 Crores year on year, a rise of 46.24%.
Consolidated Net Profit of ₹2.84 Crores down 1.39% from ₹2.88 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.49, down 11.31% from ₹1.68 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.